Hap Trading, LLC Ardelyx, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 12, 2023	SELL	$2.68 - $4.79 $40,200 - $71,850	-15,000 Reduced 48.54%	15,900 $31,000
Q4 2022 Feb 14, 2023	BUY	$1.22 - $2.85 $20,740 - $48,450	17,000 Added 122.3%	30,900 $20,000
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.44 $21,181 - $51,696	-35,900 Reduced 72.09%	13,900 $3,000
Q2 2022 Aug 12, 2022	BUY	$0.51 - $1.17 $6,426 - $14,742	12,600 Added 33.87%	49,800 $2,000
Q1 2022 May 12, 2022	BUY	$0.65 - $1.18 $3,380 - $6,136	5,200 Added 16.25%	37,200 $7,000
Q4 2021 Feb 14, 2022	BUY	$0.86 - $1.7 $18,748 - $37,060	21,800 Added 213.73%	32,000 $7,000
Q3 2021 Nov 10, 2021	SELL	$1.27 - $8.17 $14,859 - $95,589	-11,700 Reduced 53.42%	10,200 $0
Q2 2021 Aug 11, 2021	BUY	$6.55 - $8.98 $66,155 - $90,698	10,100 Added 85.59%	21,900 $15,000
Q1 2021 May 14, 2021	BUY	$6.1 - $7.69 $71,980 - $90,742	11,800 New	11,800 $4,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $787M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.